As the SARS-CoV-2 coronavirus pandemic continues to spread all around the world, the VRI is joining the global health emergency to accelerate research on the virus
and development of a vaccine. With its expertise against HIV and emerging infectious diseases, including Ebola recently, the VRI engages all its teams on scientific
research against COVID-19.
The VRI engages its researchers, its partners, recognized worldwide in the fields of infectious diseases, vaccinology, immunology, data sciences, its advanced technologies
and its network in France, Europe and the USA, to respond to the COVID-19 pandemic.
See the press released